Aviva
BIVV

Aviva’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Aviva’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-61,388
Closed -$3.31M – 736
2017
Q4 		$3.31M Sell
61,388
-7,771
-11% -$425K 0.02% 626
2017
Q3 		$3.95M Buy
69,159
+930
+1% +$54.5K 0.02% 606
2017
Q2 		$4.11M Buy
68,229
+70
+0.1% +$3.99K 0.02% 605
2017
Q1 		$3.71M Buy
+68,159
New +$3.36M 0.02% 630

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Aviva's BIVV Position: Q1 2018 in Review

Aviva sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 61,388 shares — an estimated $3.31M sold.

Aviva first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $4.11M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Aviva reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Aviva sold 61,388 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $3.31M.
  • Aviva first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Aviva's Bioverativ Inc. Common Stock position peaked at $4.11M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Aviva's 13F filing for Q1 2018, filed 14 May 2018.